This online appendix presents additional results on the efficiency and optimality of the three-group design. The first set of figures (Figures 1 -3) replicates Figures 1 -3 in the paper; the other 9 sets of figures show results for different sets of parameter values: the proportion of compliers (α), the treatment effect (τ ), the probability of voting given treatment and contact (π C T ), and the probability of voting given no contact in the treatment group (π C ). These parameter values are displayed in the topright corner of each graph.
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